Analyst Price Targets — HYPR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 22, 2024 6:17 am | Larry Biegelsen | Wells Fargo | $1.60 | $1.01 | StreetInsider | Hyperfine Inc. (HYPR) PT Lowered to $1.60 at Wells Fargo |
| August 11, 2022 10:19 am | Larry Biegelsen | Wells Fargo | $2.40 | $1.50 | TheFly | Hyperfine slides after lowering expectations, Wells Fargo downgrade |
Latest News for HYPR
GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine's most advanced portable MRI tech to European markets.
/PRNewswire/ -- USANewsGroup.com News Commentary - Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the
FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loan facility to Hyperfine, Inc. (NASDAQ: HYPR) (“Hyperfine”), with an initial funding of $15 million at closing, and up to $25 million available to support future commercial growth. Hyperfine is a publicly traded health…
Hyperfine (NASDAQ: HYPR - Get Free Report) and Atossa Genetics (NASDAQ: ATOS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk. Analyst Recommendations This is a summary of current
Hyperfine, Inc. (HYPR) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HYPR.
U.S. House Trading
No House trades found for HYPR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.